BNP Paribas Financial Markets
CDMO

BNP Paribas Financial Markets’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

BNP Paribas Financial Markets’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,608
Closed -$81.6K – 5647
2024
Q4 		$81.6K Sell
6,608
-144,914
-96% -$1.66M ﹤0.01% 4235
2024
Q3 		$1.72M Buy
151,522
+28,894
+24% +$290K ﹤0.01% 2138
2024
Q2 		$876K Sell
122,628
-187,931
-61% -$1.44M ﹤0.01% 2348
2024
Q1 		$2.08M Buy
310,559
+104,573
+51% +$719K ﹤0.01% 2029
2023
Q4 		$1.34M Buy
205,986
+149,737
+266% +$965K ﹤0.01% 2208
2023
Q3 		$531K Buy
56,249
+610
+1% +$7.34K ﹤0.01% 2692
2023
Q2 		$777K Sell
55,639
-22,762
-29% -$388K ﹤0.01% 2349
2023
Q1 		$1.47M Buy
78,401
+10,898
+16% +$179K ﹤0.01% 2048
2022
Q4 		$930K Sell
67,503
-15,212
-18% -$233K ﹤0.01% 2207
2022
Q3 		$1.58M Sell
82,715
-24,748
-23% -$451K ﹤0.01% 2138
2022
Q2 		$1.64M Buy
107,463
+3,780
+4% +$55.9K ﹤0.01% 1884
2022
Q1 		$2.11M Buy
103,683
+3,127
+3% +$63.7K ﹤0.01% 1768
2021
Q4 		$2.93M Buy
100,556
+89,564
+815% +$2.56M ﹤0.01% 1731
2021
Q3 		$237K Buy
10,992
+8,539
+348% +$206K ﹤0.01% 2982
2021
Q2 		$62.9K Sell
2,453
-6,025
-71% -$129K ﹤0.01% 3183
2021
Q1 		$155K Sell
8,478
-4,133
-33% -$68.7K ﹤0.01% 3156
2020
Q4 		$146K Sell
12,611
-1,042
-8% -$9.53K ﹤0.01% 3030
2020
Q3 		$104K Buy
13,653
+10,736
+368% +$81.3K ﹤0.01% 3095
2020
Q2 		$19.1K Sell
2,917
-14,413
-83% -$80.5K ﹤0.01% 3417
2020
Q1 		$88.6K Buy
17,330
+9,007
+108% +$54.5K ﹤0.01% 3265
2019
Q4 		$63.8K Buy
8,323
+28
+0.3% +$163 ﹤0.01% 3514
2019
Q3 		$44K Buy
8,295
+2,242
+37% +$13.9K ﹤0.01% 3550
2019
Q2 		$33.9K Sell
6,053
-4,476
-43% -$18.5K ﹤0.01% 3656
2019
Q1 		$44.7K Buy
+10,529
New +$43K ﹤0.01% 3567
2018
Q4 		– Sell
-1,657
Closed -$11.4K – 4450
2018
Q3 		$11.4K Hold
1,657
– – ﹤0.01% 3670
2018
Q2 		$6.5K Buy
+1,657
New +$5.75K ﹤0.01% 3974
2016
Q1 		– Sell
-5,298
Closed -$43.4K – 3126
2015
Q4 		$43.4K Sell
5,298
-487
-8% -$3.93K ﹤0.01% 2909
2015
Q3 		$41.3K Buy
5,785
+3,547
+158% +$29.6K ﹤0.01% 3003
2015
Q2 		$20.5K Buy
2,238
+1,639
+274% +$15.8K ﹤0.01% 3041
2015
Q1 		$5.67K Buy
+599
New +$5.77K ﹤0.01% 3080
2014
Q4 		– Sell
-2,038
Closed -$19.4K – 3312
2014
Q3 		$19.4K Buy
2,038
+2,022
+12,638% +$22.6K ﹤0.01% 3185
2014
Q2 		$207 Buy
+16
New +$202 ﹤0.01% 3707
2014
Q1 		– Sell
-281
Closed -$2.74K – 3865
2013
Q4 		$2.74K Sell
281
-5,467
-95% -$51.4K ﹤0.01% 3485
2013
Q3 		$56.3K Sell
5,748
-2,024
-26% -$20.1K ﹤0.01% 2497
2013
Q2 		$70.2K Buy
+7,772
New +$81.5K ﹤0.01% 2606

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's CDMO Position: Q1 2025 in Review

BNP Paribas Financial Markets sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 6,608 shares — an estimated $81.6K sold.

BNP Paribas Financial Markets first reported a position in CDMO in Q2 2013 and held it in 35 quarters. The position peaked at $2.93M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • BNP Paribas Financial Markets reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 6,608 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $81.6K.
  • BNP Paribas Financial Markets first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 35 quarters.
  • BNP Paribas Financial Markets's Avid Bioservices, Inc. Common Stock position peaked at $2.93M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.